Lima, L.M.A. de (2009) “ Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen ”, Clinics, 64(5), pp. 415–420. doi:10.1590/S1807-59322009000500008.